Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) (Bangabandhu)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Dr. Mamun-Al-Mahtab, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Identifier:
First received: May 1, 2012
Last updated: NA
Last verified: May 2012
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)